BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33562844)

  • 1. Ocular Phenotype Associated with
    Méjécase C; Way CM; Owen N; Moosajee M
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.
    Meissner LE; Macnamara EF; D'Souza P; Yang J; Vezina G; ; Ferreira CR; Zein WM; Tifft CJ; Adams DR
    Mol Genet Genomic Med; 2020 Dec; 8(12):e1544. PubMed ID: 33159716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular findings of albinism in
    Ernst J; Alabek ML; Eldib A; Madan-Khetarpal S; Sebastian J; Bhatia A; Liasis A; Nischal KK
    Ophthalmic Genet; 2020 Dec; 41(6):650-655. PubMed ID: 32838606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.
    Ji J; Lee H; Argiropoulos B; Dorrani N; Mann J; Martinez-Agosto JA; Gomez-Ospina N; Gallant N; Bernstein JA; Hudgins L; Slattery L; Isidor B; Le Caignec C; David A; Obersztyn E; Wiśniowiecka-Kowalnik B; Fox M; Deignan JL; Vilain E; Hendricks E; Horton Harr M; Noon SE; Jackson JR; Wilkens A; Mirzaa G; Salamon N; Abramson J; Zackai EH; Krantz I; Innes AM; Nelson SF; Grody WW; Quintero-Rivera F
    Eur J Hum Genet; 2015 Nov; 23(11):1473-81. PubMed ID: 25944381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DYRK1A mutations in two unrelated patients.
    Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
    Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
    Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
    Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phenotype of ASD-associated
    Earl RK; Turner TN; Mefford HC; Hudac CM; Gerdts J; Eichler EE; Bernier RA
    Mol Autism; 2017; 8():54. PubMed ID: 29034068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
    Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
    BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures.
    Fenster R; Ziegler A; Kentros C; Geltzeiler A; Green Snyder L; Brooks E; Chung WK
    Am J Med Genet A; 2022 Jul; 188(7):1954-1963. PubMed ID: 35285131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
    van Bon BW; Coe BP; Bernier R; Green C; Gerdts J; Witherspoon K; Kleefstra T; Willemsen MH; Kumar R; Bosco P; Fichera M; Li D; Amaral D; Cristofoli F; Peeters H; Haan E; Romano C; Mefford HC; Scheffer I; Gecz J; de Vries BB; Eichler EE
    Mol Psychiatry; 2016 Jan; 21(1):126-32. PubMed ID: 25707398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DYRK1A-related intellectual disability: a syndrome associated with congenital anomalies of the kidney and urinary tract.
    Blackburn ATM; Bekheirnia N; Uma VC; Corkins ME; Xu Y; Rosenfeld JA; Bainbridge MN; Yang Y; Liu P; Madan-Khetarpal S; Delgado MR; Hudgins L; Krantz I; Rodriguez-Buritica D; Wheeler PG; Al-Gazali L; Mohamed Saeed Mohamed Al Shamsi A; Gomez-Ospina N; Chao HT; Mirzaa GM; Scheuerle AE; Kukolich MK; Scaglia F; Eng C; Willsey HR; Braun MC; Lamb DJ; Miller RK; Bekheirnia MR
    Genet Med; 2019 Dec; 21(12):2755-2764. PubMed ID: 31263215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a human induced pluripotent stem cell line (FDCHi012-A) from a patient with DYRK1A-related intellectual disability syndrome carrying DYRK1A mutation (c.1024G > T).
    Ge Y; Cheng Y; Yin T; Peng X; Xiong Z; Wu B; Wang H; Xiong M; Zhou W
    Stem Cell Res; 2024 Apr; 76():103345. PubMed ID: 38382213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency.
    Valencic E; Piscianz E; Sirchia F; Tommasini A; Faletra F; Todaro F; Spinelli AM; Badolato R
    Immunol Lett; 2019 Oct; 214():52-54. PubMed ID: 31442541
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients.
    Dowjat K; Adayev T; Kaczmarski W; Wegiel J; Hwang YW
    J Neuropathol Exp Neurol; 2012 Dec; 71(12):1100-12. PubMed ID: 23147510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebrafish knockout of Down syndrome gene,
    Kim OH; Cho HJ; Han E; Hong TI; Ariyasiri K; Choi JH; Hwang KS; Jeong YM; Yang SY; Yu K; Park DS; Oh HW; Davis EE; Schwartz CE; Lee JS; Kim HG; Kim CH
    Mol Autism; 2017; 8():50. PubMed ID: 29021890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
    Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
    Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, genetic and histopathologic findings in two siblings with muscle-eye-brain disease.
    Zervos A; Hunt KE; Tong HQ; Avallone J; Morales J; Friedman N; Cohen BH; Clark B; Guo S; Gazda H; Beggs AH; Traboulsi EI
    Eur J Ophthalmol; 2002; 12(4):253-61. PubMed ID: 12219993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.
    Møller RS; Kübart S; Hoeltzenbein M; Heye B; Vogel I; Hansen CP; Menzel C; Ullmann R; Tommerup N; Ropers HH; Tümer Z; Kalscheuer VM
    Am J Hum Genet; 2008 May; 82(5):1165-70. PubMed ID: 18405873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.